New pivotal trial data support effectiveness of nipocalimab for gMG
Treatment with nipocalimab in gMG patients led to significant reductions in disease severity, per top-line data from a pivotal Phase 3 trial.| Myasthenia Gravis News
Treatment with nipocalimab in gMG patients led to significant reductions in disease severity, per top-line data from a pivotal Phase 3 trial.| Myasthenia Gravis News
Steve Bryson is a science writer for Myasthenia Gravis News with a PhD in biochemistry. He covers the latest news and information on a variety of myasthenia gravis topics.| Myasthenia Gravis News
Having a thymectomy was found to significantly ease neurological symptoms in MG patients older than 65 with a thymus tumor, per a new study.| Myasthenia Gravis News
